See More StocksHome

FCF

First Commonwealth Financial

Show Trading View Graph

Mentions (24Hr)

4

33.33% Today

Reddit Posts

r/wallstreetbetsSee Post

Oxy is the most undervalued company based on FCF yield on EV in the market right now.

r/investingSee Post

Booking Holdings stock analysis (Burry's 4th Largest Holding)

r/stocksSee Post

Tesla Non-GAAP EPS of $0.71 misses by $0.03, revenue of $25.17B misses by $590M

r/StockMarketSee Post

Booking Holdings stock analysis (Burry's 4th Largest Holding)

r/wallstreetbetsSee Post

Visteon Corp $VC is a no brainer at these levels

r/WallstreetbetsnewSee Post

$HITI , a hidden gem in its sector

r/pennystocksSee Post

$HITI, a hidden gem in its sector

r/ShortsqueezeSee Post

$HITI , the most undervalued company in its sector and the best performing

r/weedstocksSee Post

$HITI , the most undervalued company in its sector and the best performing

r/wallstreetbetsOGsSee Post

$HITI , the most undervalued company in its sector and the best performing

r/RobinHoodPennyStocksSee Post

$HITI , the most undervalued company in its sector and the best performing

r/stocksSee Post

DocGo($DCGO) Looking cheap now?

r/stocksSee Post

Isn't Amazon stock (AMZN) a bad investment?

r/wallstreetbetsSee Post

ZIM: Betting on Red Sea Conflict

r/wallstreetbetsSee Post

I was right about WIRE. I was right about ANF. I haven't been right about DQ.... yet.

r/ShortsqueezeSee Post

Tired of $BOWL shills so here's some DD

r/stocksSee Post

Is MNST still the king of energy drink investment for 2024?

r/wallstreetbetsSee Post

Credit Scores? FICO already halfway to the moon

r/wallstreetbetsSee Post

Buy TTGT for big monies

r/stocksSee Post

SNPS price drop -> soon fairly valued?

r/stocksSee Post

$FLNC - High Growth Battery / Energy Storage Stock Trading At A Low Growth-Based Valuation

r/stocksSee Post

European oil & gas stocks

r/wallstreetbetsSee Post

Netflix Is Going Down

r/wallstreetbetsSee Post

Shift4 - Discussion

r/StockMarketSee Post

Alibaba Group: Navigating with “1+6+N” into Digital Era

r/StockMarketSee Post

Fortinet Inc. – Navigating Turbulent Waters with a Steady Hand

r/StockMarketSee Post

Pool Corp Stock (My Thoughts)

r/wallstreetbetsSee Post

Duck, duck, $GOOS!

r/wallstreetbetsSee Post

CRWD Earnings Alert: Everything you need to know 🚀🔥

r/investingSee Post

Thoughts on PayPal (PYPL) - A few of my thoughts

r/stocksSee Post

Seeking Guidance on NPV Calculation in My First DCF Analysis - Are Negative Free Cash Flows a Red Flag?

r/wallstreetbetsSee Post

YOLO for Organon- Women's health company under siege

r/stocksSee Post

Tesla's earnings should improve in Q4; short TSLA puts now for income.

r/stocksSee Post

BABA drop overdone?

r/pennystocksSee Post

DD on Plurilock AI, A cyber security company

r/investingSee Post

Please Roast My Portfolio

r/WallstreetbetsnewSee Post

DD on Plurilock AI, A cyber security company

r/RobinHoodPennyStocksSee Post

DD on Plurilock AI, A cyber security company

r/smallstreetbetsSee Post

DD on Plurilock AI, A cyber security company

r/WallStreetbetsELITESee Post

DD on Plurilock AI, A cyber security company

r/investingSee Post

StoneCo(STNE) Is it a buy?

r/stocksSee Post

StoneCo(STNE) Is it a buy?

r/investingSee Post

Dlocal(DLO) Undervalued opportunity?

r/stocksSee Post

Dlocal(DLO) Possible opportunity?

r/stocksSee Post

Solo Brands(DTC) Undervalued?

r/stocksSee Post

InPost Group: Q3 EBITDA up 40% yoy, Q3 EBIT up 75% yoy. Revenue +22% yoy, net leverage down

r/stocksSee Post

How to find a good price to buy

r/stocksSee Post

$SHYF - following up (cross-post)

r/investingSee Post

Financial ratios used for evaluating stocks; is ChatGPT right??

r/investingSee Post

Inmode - Medical devices - break my thesis

r/stocksSee Post

Crocs Stock Analysis (CROX)

r/pennystocksSee Post

Canada Nickel Announces Positive Bankable Feasibility Study For its Crawford Nickel Sulphide Project $CNIKF

r/pennystocksSee Post

Promising Penny Stocks $CMRA, $FCF, $NOTE

r/stocksSee Post

PEP vs KO: some questions about evaluation

r/weedstocksSee Post

Most undervalued companies in the space based in metrics

r/stocksSee Post

Thoughts on Lockheed Martin (LMT)

r/stocksSee Post

SBF and Elizabeth Holmes: introduced to the world same fluff piece writer; Spotting fraud in finance since writer's public intro to geniuses

r/StockMarketSee Post

Nathan’s Famous Write-Up

r/investingSee Post

Iterating wacc. How does it work?

r/StockMarketSee Post

McDonalds Finally worth looking at

r/SPACsSee Post

Tritium DCFC Is Stuck In A Death Spiral Financing Trap

r/stocksSee Post

BRC- Brady Corporation, company overview and valuation

r/wallstreetbetsSee Post

Thoughts on NKE?

r/stocksSee Post

Chevron - a bleak outlook

r/StockMarketSee Post

Help needed with MCD valuation

r/stocksSee Post

ADBE fair value and entry points for long term

r/wallstreetbetsSee Post

Oil screening. Most important metrics

r/wallstreetbetsSee Post

SWBI 👀👀

r/stocksSee Post

Isolating the anti ESG discount

r/stocksSee Post

British American Tobacco: Heads I win, tails I…still win

r/stocksSee Post

MercadoLibre seems absurdly undervalued.

r/investingSee Post

Value driver formula in practice

r/stocksSee Post

How to weigh valuation metrics

r/stocksSee Post

What is up with Brookfield renewable ($BEPC)? - just hit all time low

r/weedstocksSee Post

Impact of no 280E on FCF for MSOs

r/wallstreetbetsSee Post

3M Company, is it a Buying Opportunity?

r/StockMarketSee Post

ZoomInfo Technologiez

r/wallstreetbetsSee Post

Update: Splunk (SPLK) Due Diligence

r/stocksSee Post

JPMorgan Chase Analysis and Financial Statements

r/wallstreetbetsSee Post

How u/deepfuckingvalue crushed the markets

r/investingSee Post

NVIDIA - Sh*t! If the margins they reported are the new trend of this company... $Trillions to come in Mark.cap?

r/WallStreetbetsELITESee Post

The DFV Method(update)

r/stocksSee Post

Royalty Pharma (RPRX)

r/stocksSee Post

ASML - Fair value based on DCF

r/stocksSee Post

Paypal is NOT Blockbuster, It's Netflix- Deep Dive Analysis -Stablecoins

r/investingSee Post

Sankyo Corp establishing a Monopoly in japan

r/stocksSee Post

Paypal can buyback 19% of its entire company today

r/stocksSee Post

Paypals New Ceo could be original Founder Max Levchin

r/stocksSee Post

Gefran SPA - Italian small cap

r/stocksSee Post

HelloFresh stock analysis and valuation - One of my largest positions

r/stocksSee Post

Beginning “investor” with a few questions about analyzing companies

r/stocksSee Post

My Paypal updated thesis

r/StockMarketSee Post

Q2 LUMN Earnings Report 2023

r/investingSee Post

LUMN Q2 2023 Earnings Report

r/wallstreetbetsSee Post

PYPL to the moon

r/investingSee Post

Explanation for huge FCF differences between analyst expectations and actual?

r/pennystocksSee Post

$BTBT is back with a vengeance, up 7%. Yesterday's biggest gainers were $MARA, $RIOT, $CLSK, $HUT, and $BKKT.

r/wallstreetbetsSee Post

Why SNAP is Extremely Undervalued

r/wallstreetbetsSee Post

Natural gas price recovery: a tale of two tickers (AR and RRC)

r/wallstreetbetsSee Post

Susquehanna analyst Charles P. Minervino reiterated a Positive rating on RTX Corporation (NYSE:RTX), price target to $110.

Mentions

It’s something to keep an eye on but they can afford it. I think that Meta is one of the more dangerous mag 7 stocks, but far from one of the most risky AI stocks in the market. Even after this pullback the stock is up 460% over the past 3 years so there’s no harm in taking profits at this level. They’re essentially at 2023 levels of Free Cash Flow. In the Trailing Twelve Months compared to FY 2023 their OCF grew from $71B to $107B ($36B) and their Capex grew from $27B to $62B ($35B). Their OCF is growing rapidly (averaging 22% per year since 2020) so they likely are seeing effects of AI, but I always assume that the company will earn 0% return on their AI spend. Would you be happy owning Meta producing $45B in FCF after earning $23B in 2020, $39B in 2021, $19B in 2022, $43B in 2023, $54B in 2024, and $45B in TTM which is close to FY 2025? 37x FCF is too expensive for me to pay especially considering that FCF will likely be lower next year due to increased capex. It’s not something I would want to own, but $45B FCF companies aren’t everywhere and they won’t go out of business if they get no return on their AI spending.

Mentions:#FCF

Dude, stop buying puts on TSLA for your own good. We all know it's 5-10x overvalued using a FCF or EPS model, but it genuinely does not trade on fundamentals. When people say it trades as a meme stock, to be more precise, it trades on short-term options activity and the subsequent price action that results when market makers (who buy or sell options) need to buy or sell the underlying to cover up their underlying. Consider TSLA vs. MSFT and BRK.B. I chose these because they are also two megacaps in the trillion dollar club and because they have similar prices per stock, meaning that the value of each options contract will be similar. Now look at how much difference there is between the option volume for the 0DTE: |Underlying|Current Price|Call Volume|Put Volume| |:-|:-|:-|:-| |[TSLA](https://optioncharts.io/options/tsla)|480.09|831,847|542,274| |[MSFT](https://optioncharts.io/options/msft)|487.47|30,369|13,214| |[BRK.B](https://optioncharts.io/options/brkb)|498.20|1,652|1,228| TSLA has nearly 30 times the 0DTE call volume of MSFT and more than 500 times the 0DTE call volume of BRK.B. Those stocks trade on expectations of future earnings, TSLA trades on arbitrage and hedging. You might think you're smarter than an army of apes, but they're going to rip your arms off until enough of them leave.

I’m at work so can’t do a big response atm. But I was seeing SpaceX 2025 revenue around $15.5B so at $800m that’s 50x sales and where I got the 100x for the $1.5T target. Also should note their revenue in 2024 was over $13B so they had 10% growth. RKLB is like 50%. I also meant to specify that RKLB is for sure overvalued. Not trying to say it’s a value stock or even a buy at these prices. Rather that I think it’s a better buy with less risk than SpaceX IF they ipo at $1.5T. You may be right and 2026 sucks, but long term the price today isn’t gonna matter at their growth rate. To the r&d cost thing, RKLB should be FCF positive by the end of 2026 into 2027. They have enough cash on hand to maintain their level of spending for over 2 years (not counting the reduced cost once neutron is finished). So dilution really isn’t an issue, unless they want to make an acquisition but they’ve proven to make good acquisitions that benefit shareholders. The point is they don’t *have* to dilute shares to keep operations and r&d going. Ofc SpaceX is in a better financial position and are FCF positive since they’re a more mature company with an unlimited budget. Lastly, is neutron works out as planned their ability to scale should be insane since they’re can 3D print the majority of the rocket and engines. The margins with reduced labor costs will likely be the best in the industry once they scale neutron. Outside neutron, electron will have about 30-35% gross margins next year (once they hit 24+ launches a year) and the space systems (core business) already has something like 40% gross margins with long term goal of 45%. Yeah I know net margins are sorta more important but there can be some accounting. Long term you’re right margins won’t reach tech levels but they should be pretty high.

Mentions:#RKLB#FCF

FCF growing, balance sheet getting better, business not dying but priced like it is…

Mentions:#FCF

After their new acquisition of New Gold they're going to compete with the big boys soon. I'm holding CDE long term now. Currently holding over 9,000 shares. Had 12K at one point but took profits. Imagine the fucking ludicrous profits they're going to be announcing at these gold and silver prices. I mean, what the actual fuck it's going to be insane. FCF is going to be wild. Coeur Mining saw it and pounced on the next big thing, with exposure to copper as well. Good luck bro. Don't get impatient.

Mentions:#CDE#FCF

You’re talking like it’s an investment. It’s a horrible investment that is pre-revenue. No one has any idea of they’ll last 10 years, or able to actually earn FCF. This is buy the rumour, sell the news. Only an idiot would actually hang on long term. If you really want to hang on, wait for it to do double, and then sell 75% of your shares. This way you’ve dumped most of your position while profitable, and still hold something in case it continues to fly.

Mentions:#FCF

1. Get a birds-eye view of the company. What does the company do? How do they make their money? What sector are they in? Tailwinds/headwinds in the industry? Who is the CEO? What is current sentiment? What direction is the business going and what stage in the business cycle is it at currently? 2. Look a little deeper into the fundamentals of the stock. I personally look at: market cap, revenue growth, profit margin, margin growth, book value, forward PE, EPS, debt, FCF, revenue/margins of each of the business’ market sectors (ie Amazon’s retail financials and their AWS financials). I am personally looking for two things here — 1, proof of growth potential and 2, disqualification. If any of these numbers are red flags based on my understanding established in the first step, I move on or dig deeper depending on the company. Basically, you want to see profitability, growth potential, and the ability to survive if something goes wrong. 3. Look below the hood. This can often tell you more than anything else. Are there share buybacks going on? What is the dividend history? What is the short ratio? What level of institutional investment is there? What are industry analysts’ price targets? Are there any catalysts on the horizon? Potential regulatory hurdles? Is the industry faring well? Who are the primary competitors? What is the company’s position in the industry? How can they grow/maintain market share? Who are the business’ customers? Are they stable? Is there a backlog? What about their suppliers? Are they sensitive to interest rates, commodity prices, consumer sentiment, etc.? Is their success dependent on another company? Is a M&A angle in play? What ETFs are the company included in, how is the fund performing, and will it be added to the DJIA/S&P500/QQQ etc. in the near future? 4. Look at the stock’s price. Compare to 52w high and low. Compare to ATH & ATL. Look at volume patterns. See if there is a base of support in the chart or resistance spots. Compare to the chart of similar companies. Compare to the S&P500. Looking for momentum & support levels; I’m a believer in time in the market, so this step is primarily to determine position sizing, if I’ll be DCAing or lump buying, etc. 5. Check out different sources to see if anyone has information you missed. I personally start on Reddit, then use some combination of YouTube, Yahoo! Finance, Morningstar, Moody’s, IBD, Bloomberg, WSJ, & CNBC. 6. Look at your portfolio. How would this stock change its composition? Does it improve your expected returns? Add/reduce volatility? Affect the Sharpe ratio? What sizing should you use? Does it improve diversification? Is it redundant? What is the r/r to adding it? What is the opportunity cost of tying up money in this stock? 7. At this point, you should have a really solid feel for the business. You should know whether you want to buy or not. If you do, pull the trigger now. You have done the research. Trust yourself. If you don’t, put it on the watchlist, and note why you didn’t buy. If something materially changes, it may become a good investment. 8. Come up with your thesis. Why are you buying, what are the exit strategies, what will you do to mitigate risk. Plan for a worst case, best case, and base case scenario. None of this requires advanced quant analysis, specialized data or tools, or anything more than about an hour of your time. I research 2-3 stocks per day. I have a running list of 1000+ stocks sorted by industry & market cap within the industry. I only launch this process if I want to buy. It’s worked well for me. You don’t need to spend too much time on any one step, but unsatisfactory results for any of the steps disqualifies it from investment in my strategy. You should at least consider each of the factors I’ve listed, though you don’t have to go down the list like a checklist. Use your brain, not your heart. Most importantly, write things down. Anything you feel may be important. Start a fresh sheet of paper/new document for your notes and findings while you’re researching each stock and then save it in a folder regardless of if you buy or not. You’ll very quickly build up a reference library of DD that you can return to for many reasons. Perhaps to invest in the future if the situation changes, perhaps to look back at successes and see what led to the success, perhaps to look back and see where you erred in logic if a stock doesn’t meet your expectations. Information is power. The more you do this (and not rely on others) the more confident you’ll be in your ability to analyze a stock. I’m at the point where I don’t really care what anyone else says about a stock if I’ve researched it and formed an opinion. I trust my ability more than anyone else’s, and you will too. Trust me. Dm if you’d like more info/guidance

Up until now it’s been all about AI infrastructure, 2026 will be about applications and use cases now. Agentic AI should outperform the chips and data centers. I’m long CRM and PATH to play that angle, but also like NOW despite the M&A overhang. Also very bullish RBRK which has flipped into positive earnings and FCF while still growing sales rapidly.  BA probably outperforms this year as well with the same principle, flipping FCF positive with commitments underway. 

The law hasn't changed, and it might not (there's a chance they blame this and that). Trump signed a document, he did his part. Since Feb '21 the entire sector has been in decline. There has been ZERO federal reform since then, and this EO isn't reform. Most companies are generating losses, and only a few (like maybe 2 or 3) are truley FCF+ after taxes paid. A few more are FCF+ but hold tax liability on the balance sheet. The revenue growth is basically stalled. Look at the acutal P/E ratios of these companies. They aren;t cheap, especially since projected growth isnt much. What part about these makes you bullish on "macro"? Since Feb '21 - Cole memo removed, bank custody removed - so if anything it's actually gotten more restrictive. There will undoubtably be an explosion of optimism if S1->S3 officially. Can that overcome strategic short selling, especially when hunting to expire ITM calls worthless (I have absolutely no idea)? How do you "invest" in this sector? It's in perpetual decline. You can only trade it. To even consider the tide is turning, MSOS needs to clear 11.40 to break weekly market structure. Anything below that is still HTF bearish trend, or at best within a long-ass accumulation range. Nothing so far has changed the HTF bearish structure since 2021. Is this bullish macro in the room with us?

Mentions:#FCF#MSOS

Once robotics automate $Amzn We will see 30%+ FCF that's $130B FCF COMING RIGHT UPPP

Mentions:#FCF

Anyone here follow **STVN?** Came across them screening this morning, kind of an interesting name. This is what they do: >Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. >It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass forming machines; and after-sales services, such as spare parts and maintenance services. They have some exposure to GLP1s, but worry about the pill taking off. Kind of a smaller float name too. From a PE level, it's a bit high, but PEG is at 1.5, so if they can keep up the growth, it's somewhat a fair value price. [https://finviz.com/quote.ashx?t=STVN&p=d](https://finviz.com/quote.ashx?t=STVN&p=d) Sounds like they are trying to expand more into the US, so CAPEX could weight down some of the FCF. [https://ir.stevanatogroup.com/news-events/press-releases/detail/165/stevanato-group-secures-200-million-in-financing-from](https://ir.stevanatogroup.com/news-events/press-releases/detail/165/stevanato-group-secures-200-million-in-financing-from) Here's the last ER press release: [https://d1io3yog0oux5.cloudfront.net/\_aae890553e83cfe634709424614dffec/stevanatogroup/news/2025-11-06\_Stevanato\_Group\_Reports\_Revenue\_of\_303\_2\_Million\_171.pdf](https://d1io3yog0oux5.cloudfront.net/_aae890553e83cfe634709424614dffec/stevanatogroup/news/2025-11-06_Stevanato_Group_Reports_Revenue_of_303_2_Million_171.pdf)

Amazon has the potential to be the world’s first 10 trillion dollar company. However, that doesn’t mean they necessarily will… but they *could*. To get there, Amazon could choose to turn on the money printers whenever they want and generate monstrous free cash flow. More FCF than any company on Earth. We got to see a brief glimpse of that before they began spending like crazy on capex within the last year. Why don’t they stop spending? The prudent move for the company is to invest in AI. It is simply too great of an opportunity to pass-up. Advertising, AWS, 3rd Party Seller Services, and Subscriptions are all high margin segments of Amazon that are all growing fabulously. AWS isn’t all there is at Amazon. That’s an outdated narrative. Robotics have the potential to synergize their network, making tight margins high and high margins even higher. Amazon’s share of global retail is still only 4-5%! Their runway is still unfathomably large. Their TAM may as well be infinite at this point in time. Additionally, Amazon still has not instituted a capital return program in the form of dividends and/or buybacks. An annual share buyback program could go a long way towards compounding their stock price. I hold a lot of Amazon. I’m fine accumulating them silently while the market hysterically follows other opportunities. Amazon’s day will come, and their potential gains can still be face melting. The bet here is asymmetrical. There isn’t much risk investing in arguably the most important and valuable American business. As far as I’m concerned, Amazon will be worth 10 trillion dollars at some point. The matter of when is the only question. From here, that’s a 4x gain…

Mentions:#FCF

I’ve been in Uber since earlier this year at $60 and have more conviction than ever that they have a bright future. There is not going to be a winner takes all scenario like some imply. As bullish as I am I hesitate to say it’s severely undervalued. I’ve plugged in different inputs using FCF and I come out in the $90-100 range myself. I think if management executes like I think they will then it most certainly could be a trillion dollar market cap in the next decade.

Mentions:#FCF

i was looking at AROC and they seem to have had heavy CAPEX in some of the recent quarters leading to low / -ve FCF in some of them. Were you able to get comfortable with the drivers of that? Also, just wondering whether you have looked at FTI?

FCF is easily manipulated, just offer lots of Stock-Based Compensation and that line gets added into

Mentions:#FCF

I know, right? When you do FCF analysis, it’s based on operating cash flow. Amazon isn’t become less profitable.. it’s making more.. I’m buying for AWS and robotics. Look pretty good to me at 28x next years earnings. Could care less about the retail business apart of marketing and the potential to leverage robotics as a massive moat.

Mentions:#FCF

Not so much in this case. Amazon has low FCF due to high Capex. They have high Capex due to very high demand for AWS. So the Capex will likely result in increased future FCF.

Mentions:#FCF

Due to high CAPEX which will improve future capacity. Even if Ai buildout turns out to be a bubble, just reducing their CAPEX budget will bring FCF right back up as their OCF is relatively stable despite macro conditions

Mentions:#CAPEX#FCF

Fiserv FISV looks like a classic special situation to me. The market is still anchoring to guidance and communication from the previous management, while the new management team hasn’t fully proven itself yet, so there’s understandable skepticism. That said, the new leadership actually looks quite strong on paper. The CFO is ex-Global Payments with VC experience, and the co-president is the former Stripe CFO. That’s a meaningful upgrade in fintech and payments expertise. Strategically, their plan to integrate services makes sense, especially in the current AI environment where rewriting legacy systems, reducing tech debt, and optimizing operations are finally becoming feasible. They’re also looking at AI primarily as an optimization lever (not hype), and they’re investing in a stablecoin strategy that could meet global merchant needs and improve cost efficiency over time. While management still needs to prove execution, I found the Q3 earnings call refreshing. The tone was one of candor, not promotional optimism, which I actually view as a positive signal at this stage of a turnaround. From a fundamentals standpoint, the company generates strong and consistent free cash flow. Even with leverage on the balance sheet, the FCF quality is solid. With ongoing optimization, product integration, and platforms like Clover, I think there’s a reasonable path to mid-term earnings growth. This is still a competitive and capital-intensive industry, so it’s not without risk. However, payments and financial infrastructure continue to grow globally, and Fiserv has meaningful exposure to international markets. At the current valuation, the stock looks closer to a bargain than a value trap, in my view, and I see it as an attractive 3–5 year investment if management executes.

Mentions:#VC#FCF

Adobe is probably my #1 pick for 2026-2030. One of the highest quality business in the word, growing at 10+%, margin expansion (insane, already at 89%), FCF machine and huge buybacks.

Mentions:#FCF

What we're seeing happening to Nike has been happening to Lululemon as well, granted that, as a few other posters here have said, Nike lacks growth opportunity in China, while Lululemon has that opportunity. But, they struggle with the same increased competition, tariffs & margin contraction, partly fueled by tariffs. I've seen some commenters mention that revenue figures are "up", this is probably one of the worst numbers you could be looking at this time in Nike's cycle, they're pushing heavy discounts to further sales, and this is evident in the contracting gross-margin which, contrary to popular belief, isn't entirely tariffs driven. A much better look into their financials is in terms of EBITDA margins and FCF, where both have been heavily weakening over the years due to these struggles that have seen no fundamental change. Nike has been very sluggish on turning over their inventory, it is getting increasingly difficult for them to sell (without discounts), which temporarily propped up uFCF. fwd PE is at \~31x which is well above all comps, and honestly can't be justified by brand equity; we're clearly seeing a shift away in discretionary purchases towards cheaper newer alternatives. I think something interesting to talk about is what came out in the news recently about Lululemon, Elliott took a large stake & is looking to place a turnaround CEO in the position. They noted core problems with Lululemon are: (1) Brand Dilution and Discounting (2) Lack of Innovation & Newness for Newness' Sake (3) Strategic Drift Beyond the Core (4) Leadership and Execution Problem 1 is the same as Nike's, and was the same at Ralph Lauren prior to its turnaround. Problem 2 is same as Nike, though it's a bit unclear what Elliott means by "innovation" imo (it's clothing & apparel after-all). Problem 3 is similar, but in a different way, for lululemon it meant drifting from the core leggings, whereas Nike this seems to be traditional partnerships, shoe lines, etc. Problem 4 directly contradicts the other commenter referring to Nike needing a non-"woke" CEO, Lululemon has one, and they're struggling. For a company as large as Nike, it's going to be a long ride and very difficult turnaround that is unlikely to begin with current management and compensation structure. Catalysts seems very far out, while sluggish returns are much closer and realistic. **TLDR: NIKE is trading above all peers and a turnaround seems unlikely and complicated with their core issues. This is not a stock to buy at these levels.** *Note: This is just a quick surface-level overview of Nike, if anyone is truly interested, I'm happy to do an entire write-up over the weekend to further my points.*

Mentions:#FCF

Being in Broadcom for years I’d say it’s the most diversified of the semiconductor companies. They have a near 50:50 split in revenue from semiconductor revenue and software revenue after the VMware acquisition. Along with that if you are bullish on the future of ASICs or simply Google TPUs (Broadcom is their partner to make them) it might be the only company which holds a candle to Nvidia long term. Their earnings were great, but investors just didn’t like the QA of the call where Hock Tan really didn’t give much clarity on how much of the 500b backlog we can expect to see in 2026. The company will rally again once sentiment shifts. Today’s valuation is definitely at a premium, so even this dip doesn’t make it “cheap”. However, if you believe in their long term execution to increase FCF to 78b by 2028 it’s trading at around 20x FCF which is reasonable.

Mentions:#FCF

Important fundamentals don’t change over time - moat (pricing power, sustained market share, high entry barrier, high ROIC, etc. as signs), good economics (ROE, sustainable margins), predictability (risks are manageable on most fronts, and downside case not too detrimental), valuation (discount vs FCF, margin of safery). In an environment of excess liquidity and narratives-driven concentration (today), I look away from AI hype and even outside US most of time now, to find high quality ones. Plenty undervalued sectors / stocks - I think housing related ones are cheap in the US, and I think China consumer stocks are too beaten down, etc. and many are overvalued - SaaS stocks are not valued right today, their multiples and margins will be lower given AI’s commoditization forces and SaaS integration of AI / upcoming R&D and S&M spend to stay relevant with AI.

Mentions:#ROE#FCF

I can tell you’re not a very good trader. It likely stems from your low impulse control. That’s why you don’t want to share. I have a nearly 700% gain since inception now. I’m sorry that it bothers you that meditation is an important component in trading. https://imgur.com/a/V2mSt4h I would recommend you start box breathing 4-4-4-4 to relax your nervous system and look at BMBL and BRCC. Bumble is being priced for failure with a 2 year payback on FCF. BRCC insiders have been buying heavily. Those are my next two major bets. Namaste ☺️

AROC is basically the leader in natural gas compression. The bad side is the capex to upgrade some of their equipment and some lumpy FCF, which has concerns around the dividend. However, still good growth. EXFT is more of a turn around story of recent. Been working on debt levels, but have a good backlog and strong relationships with clients in the Permian basin.

Mentions:#AROC#FCF

Great question, I’m glad you asked! I don’t think there is one specific catalyst as much as there is an enormous misunderstanding about ADBE’s existing general value proposition mixed with an exaggerated fear that AI competitors will significantly eat into ADBE’s marketshare. It’s not really necessary for ADBE to suddenly have some major change that inflates their valuation massively (though that is a possibility given the growth they are making on their own AI models and the strategy behind it), it’s that people are prematurely making assumptions that AI competitors are eating up ADBE’s marketshare in a way that has not borne out in any solid numbers so far, but that has caused people to sell off the stock despite it’s ongoing earnings growth. First of all, when you say ADBE is down on the 5 year charts, I assume you are talking about the share price. But virtually every other metric looks exceptional. Here are some numbers from the last 5 years (I did Q3 since I already had the math, even though Q4 is out now): Net Income (Trailing Twelve Months) - Q3 2020: $3.862 billion - Q3 2025: $6.957 billion - 5 Year Growth: $3.095 billion - 5 Year Growth Rate: 80.1% - Annual Growth Rate (Average): 16% - Compound Annual Growth Rate: 12.5% Diluted EPS (Trailing Twelve Months) - Q3 2020 = $7.9375 / share - Q3 2025 = $16.0538 / share - 5 Year Growth: $8.1163 / share - 5 Year Growth Rate: 102.3% - Annual Growth Rate (Average): 20.5% - Compound Annual Growth Rate: 15.1% You might notice the disparity between their net income and the Earnings Per Share — that’s because Adobe buys back shares aggressively when they feel their stock is selling at an undervalued share price, and in that last 5 years those share buybacks have amounted to 2.6% Compound Annual Growth of EPS by itself. They can afford to do this because of their exceptional free cash flow (FCF) margins (~40%), which is exceedingly rare for companies. I’m going to bed now, but tomorrow I’ll add a follow up message going into more detail about why I think they have a winning strategy on the front of AI, which is the specific place that they might manage to get explosive growth if they can pull it off. But the point of this message was to show they don’t need to pull it off in any kind of major way to continue to do well — their numbers are pretty good even right now. Mostly, people are just afraid.

Mentions:#ADBE#FCF

Good point on EBITDA vs CFO.  It this situation Oracle isn't going to run at negative FCF for the foreseeable future. All of this capex is financed with LTD and future data center builds will be financed. They have have $19.4b in operating profits and interest payments are about $3.8b a year. Something to keep an eye on but not an issue. They can't do this forever but it is a huge build out which should start generating revenue in the next year. Tons of levers to pull if they are worried about it but why would they be worried about it. 

Mentions:#FCF

It should have went down when the deals were announced to be fair, because they are negative FCF deals

Mentions:#FCF

**SNDL Inc – Long-Term Bull Thesis (3–7 yrs) | NASDAQ: SNDL** * Market Cap: \~$536M | Cash: \~$178M | Debt: $0 | FCF 2025: \~$35–40M, projected $50M+ (2026) * Canadian ops: liquor (Ace Liquor, Liquor Depot, Wine & Beyond) + cannabis retail (Spiritleaf → Value Buds) + cannabis cultivation/production → stable cash flow * U.S. optionality via SunStream USA: \~$260M convertible debt → equity in FL, TX, MI, MA, NM → Top-5 North American MSO potential if federal legalization (Schedule III) occurs * 2025 revenue: $723M USD; Gross Margin \~26%; owner earnings \~$40–45M * Valuation: DCF & SOTP suggest $4–6/share vs current \~$2.10 → \~2–3x upside * Catalysts: U.S. federal rescheduling (removes 280E), SunStream conversions, Canadian consolidation, margin expansion via Indiva/private-label products * Capital Allocation: share buybacks $120–150M, Canadian tuck-ins $40–80M, U.S. roll-up via SunStream $150–300M **Bottom Line:** FCF-positive, cash-rich, undervalued Canadian retailer with embedded U.S. MSO optionality → asymmetric 3–7 yr upside.

In what would is it certainly underpriced. It has a P/(FCF - SBC) ratio of 72 and it's up 57% YTD. Do you think that's normal in any way? Of course it isn't.

Mentions:#FCF#SBC

It's a 3.6T market cap company that's up 57% YTD and has a P/(FCF - SBC) ratio of 72. It's a terrible time to buy the dip.

Mentions:#FCF#SBC

What are you smoking? They just reported their highest FCF ever.

Mentions:#FCF

Is it desperation if we expect MU to rescue the entire equities market? Great beat but 0 FCF. That's a red flag.

Mentions:#MU#FCF

Decent valuations? They owe 125B to in leases. Information reported they were making only making 20% margins off H100. Other reports -70B total FCF until 2030. They either have to cancel deals or risk being huge debt load and no way to pay off the debt Its like you taking out a 5M mortgage on 100K income

Mentions:#FCF

Well said. JPM's recent paper is spot-on. https://privatebank.jpmorgan.com/nam/en/insights/markets-and-investing/ideas-and-insights/is-ai-a-bubble-here-are-5-ways-to-find-out. At a recent conference, the head of Bain's real estate practice offered even more staggering numbers. The contraction in FCF of the hyperscalers is eye-popping: \~60% + of FCF committed to CapEx spend through 2030 by Meta, MSFT. And then there is Oracle. Publicly traded real estate is trading at a 25-year relative low. Pension fund allocations to RE are generally below target due to profound value contraction and redemptions over the past 5 years. It could be time to look at public REITs, in particular in industrial and retail, where OpEx creep and rent contraction are far less onerous than they are for office and multifamily.

Mentions:#JPM#FCF#MSFT

It's extremely overpriced. It was at fair value at $150 a share in the middle of this year. Now it's the most expensive in its history in many aspects. Record Price/Sales, record EV/FCF, increasing CapEx means more of the income goes towards just maintaining their datacenters and infrastructure. Come back when it's trading at 4-5x sales.

Mentions:#EV#FCF

googl P/FCF is almost 50...

Mentions:#FCF

Not long, but seems interesting. It's hard to find battery names and BESS names that I want to invest in, since a lot aren't at valuations I like or even generating FCF. Just a lot of speculative stuff gets hit whenever there is going to be down turns in the market. There's a canadian name I came across that is kind of interesting, but marketcap/price might be too small to share, but they are opening a factory in the US soon and now becoming profitable.

Mentions:#BESS#FCF

NFLX is overvalued from a FCF perspective and the drama around WBD acquisition puts me off. They may end up overpaying for it, too. HOOD also overvalued, and it’s a business with no moat. This would be my last choice among those three. AVGO is cheap at the moment given it’s FCF and near term growth projections. Long-standing partnership with Google on their TPUs which are gaining traction as an alternative to GPUs for AI applications. This would be my pick (indeed, I have picked a bunch of shares over the last couple of days).

Meta is burning through its FCF faster than any hyperscaler and MSFT tied itself to ScamAI which it will need to bail out, so yea they don’t have any money for 3 year old neocloud gpu’s.

Mentions:#FCF#MSFT

Yeah I saw your DD. Believe it or not I read it. Why is PMI fcf higher, and why is their FCF growth qoq at a higher rate? Their conversion rate seems to not matter if their debt is unsustainably high compared to PMI and their FCF growth is immediately eaten up by that massive dividend

Mentions:#DD#FCF

Yeah, this has been the thing holding Shift4 back and the million dollar question as to whether and when the stock takes off. Investors want to see them start paying down that debt so all these FCF projections start coming true. They seem more interested in short-term acquisitions and stock buybacks. They might be right to do that in the long-term, but it has made figuring out the entry point for them a nightmare. And meanwhile they've got short-term headwinds with the hospitality industry in retraction. I still like the thesis behind the company, but it could be rocky until the likely catalyst of the World Cup.

Mentions:#FCF
r/stocksSee Comment

The PE is wrong because of one-time injections. Look at P/OCF and P/FCF instead of exclude this.

Mentions:#FCF

I still like it, it’s grown to a pretty sizable position from my 4% allocation at $313. It’s close to 10% of that portfolio now, so I’m not adding. Honestly I’m not a fan at adding much at near highs regardless, but if I didn’t have a position I’d maybe buy 1/4-1/3 of my normal allocation. It’s still trading at like 25x FCF which isn’t bad for a company like medp. I think there may be some solid tailwinds with the new administration, may be more demand to navigate the changing rules. Also with lowing rates small biotechs will up their research and give business to medp.

Mentions:#FCF

I understand the sentiment that corporations are bad, however, what you are saying is literally the opposite of what is true. The CHIPS Act was specifically for the Micron (MU) NY, ID, and VA manufacturing facilities to expand the US supply chain for memory. MU & the USA are working together to increase the supply of memory for the US, which will ultimately lower the cost for the American people as production expands to meet demand. The money was not just "taken" it was an investment in which the US government will recoup their investment via profit share after helping the American people with the memory shortage. The asshole move by the best/largest US memory company would be if they refused to expand CAPEX/production and just turned the FCF machine on to create the most shareholder value.

Mentions:#MU#CAPEX#FCF

It first started as a liberty media share arbitrage, but they raised their stake i presume for a few reasons. First, Sirius has meaningful Price to FCF ratio of approx. 6.3 That amount of cash flow for such a low valuation is pretty extraordinary. On top of that SiriusXM is buying back a meaningful amount of shares. This along with the dividend present a pretty strong ROE case for a large shareholder such as Berkshire. Im also guessing that they believe that even with fairly modest subscriber losses, the earnings and free cash flow story wont be meaningfully effected enough for it to matter. I also think that SIRI is making some pretty big moves in investing in content to refurbish its service for newer customers. Whether that works or not, time will tell. 2026 will be a consequential year for SIRI whether their strategy works out or not.

Mentions:#FCF#ROE#SIRI

> P/FCF is ~20× - the lowest it has ever been by a mile. Isn't 20x kind of high for a company of this type? What sector is Acorn Energy in? They seem to be utilizies/hardware, which historically sits at P/FCF of around 10x on average. [Source.](https://www.stocktitan.net/articles/ev-fcf-ratio-explained#:~:text=Table_title:%20Industry%20Benchmarks:%20Know%20Your%20Playing%20Field,Industry:%20Utilities%20%7C%20Typical%20EV/FCF:%208%2D15x%20%7C) Basically high margin businesses (like Software) are usually higher P/FCF or P/E.

Mentions:#FCF#EV

Fundamentals, DCF, FCF, etc. mean nothing in this market. My responsible stocks averaged flat for the year. My speculative bs stocks made me a ton of money.

Mentions:#FCF

they grow pretty fast, but they also dilute the fuck out of shareholders. FCF per share grew like 16% per year over the last 5 boomy years

Mentions:#FCF

70x FCF multiple.. no

Mentions:#FCF

AI post made with ChatGPT explaining OpenAi circle jerk is cooked. Oh the irony, love it 👌 Last resort will be dilution, now the norm for capex datacenter and fake FCF positive stocks. Wonder who will be willing to buy when it drop another 40% tho... Difference between "discount buy" and "next stop bankruptcy" will be hard to gauge on this one 🤦

Mentions:#FCF

The valuation is simply too high, it is trading at 90 P/E (42 forward),70 P/FCF, 28 P/S. At this valuation, I won't be surprised to see it drop on good earnings, it has so many things already priced in. Not to mention they have the problem of concentration of revenue from just a few top customers.

Mentions:#FCF

I saw a comment in the daily thread that the dip occurred after it was said in the earnings report that VMware margins were slowing and that Hock Tan used the word "deterioration" to describe FCF for that business (or other?) unit.

Mentions:#FCF

The growth never really stopped. Market overreaction happens every so often (see AAPL when they stopped reporting iPhone sales, META when it dropped to like $70 and went on a non-stop 700% rally). The facts are that LULU is experiencing extremely rapid international growth with a bit of Americas slowdown. Has over $1bil in cash and increasing FCF, and no debt. I’m not going to mention its “competitors” that Redditors like to mention because they literally don’t matter and will almost likely go under in the next year. LULU’s lawsuit against Costco’s dupes tells you all you need to know about who they saw as competition.

**Trump Cannabis EO Leak (Dec 11, 2025)** WaPo reports Trump is preparing an **executive order directing HHS + DEA to move marijuana to Schedule III**. This would **end 280E**, recognize medical use, and align with Biden’s 2024 rescheduling push. White House says “no final decision yet,” but sources expect announcement soon. **Market / Sentiment:** * X: **#TrumpWeed** trending (500k+ mentions). * $MSOS up **8% after-hours**. * Reddit: 65% positive, heavy hype around **280E tax relief**. * Industry-wide benefit: **$2–3B/yr** in saved taxes. # Big Winners if Schedule III happens (280E gone) **Company | 2025 Rev | Est. Annual 280E Savings | Impact** * **Curaleaf** – $1.4B | $150–200M | Major cash unlock * **Green Thumb** – $1.1B | $100–150M | Margins 25%+ * **Trulieve** – $1.2B | $120–180M | Huge FCF reversal * **Verano** – $950M | $80–120M | Major EBITDA lift * **Cresco** – $850M | $70–100M | Debt relief + expansion * **Jushi** – \~$260M | $25–35M | Big % improvement * **Cannabist (Columbia Care)** – \~$350M | $35–50M | Margin recovery * **Planet 13** – \~$95M | $9–14M | Small cap, high % benefit * **Marimed** – \~$160M | $15–25M | Thin margins → strongest lift **Why it’s huge:** * Current effective tax rates are **60–70%** for many operators. * Schedule III removes 280E → normal 21–30% corporate tax. * Every MSO becomes more profitable **instantly** once the rule is finalized. **Bottom line:** If this EO drops and DEA confirms Schedule III, this becomes the **biggest single catalyst** the industry has ever had. Massive for MSOs and cash-strapped tier-2 players. 🚀

**Trump Cannabis EO Leak (Dec 11, 2025)** WaPo reports Trump is preparing an **executive order directing HHS + DEA to move marijuana to Schedule III**. This would **end 280E**, recognize medical use, and align with Biden’s 2024 rescheduling push. White House says “no final decision yet,” but sources expect announcement soon. **Market / Sentiment:** * X: **#TrumpWeed** trending (500k+ mentions). * $MSOS up **8% after-hours**. * Reddit: 65% positive, heavy hype around **280E tax relief**. * Industry-wide benefit: **$2–3B/yr** in saved taxes. # Big Winners if Schedule III happens (280E gone) **Company | 2025 Rev | Est. Annual 280E Savings | Impact** * **Curaleaf** – $1.4B | $150–200M | Major cash unlock * **Green Thumb** – $1.1B | $100–150M | Margins 25%+ * **Trulieve** – $1.2B | $120–180M | Huge FCF reversal * **Verano** – $950M | $80–120M | Major EBITDA lift * **Cresco** – $850M | $70–100M | Debt relief + expansion * **Jushi** – \~$260M | $25–35M | Big % improvement * **Cannabist (Columbia Care)** – \~$350M | $35–50M | Margin recovery * **Planet 13** – \~$95M | $9–14M | Small cap, high % benefit * **Marimed** – \~$160M | $15–25M | Thin margins → strongest lift **Why it’s huge:** * Current effective tax rates are **60–70%** for many operators. * Schedule III removes 280E → normal 21–30% corporate tax. * Every MSO becomes more profitable **instantly** once the rule is finalized. **Bottom line:** If this EO drops and DEA confirms Schedule III, this becomes the **biggest single catalyst** the industry has ever had. Massive for MSOs and cash-strapped tier-2 players. 🚀

**Trump Cannabis EO Leak (Dec 11, 2025)** WaPo reports Trump is preparing an **executive order directing HHS + DEA to move marijuana to Schedule III**. This would **end 280E**, recognize medical use, and align with Biden’s 2024 rescheduling push. White House says “no final decision yet,” but sources expect announcement soon. **Market / Sentiment:** * X: **#TrumpWeed** trending (500k+ mentions). * $MSOS up **8% after-hours**. * Reddit: 65% positive, heavy hype around **280E tax relief**. * Industry-wide benefit: **$2–3B/yr** in saved taxes. # Big Winners if Schedule III happens (280E gone) **Company | 2025 Rev | Est. Annual 280E Savings | Impact** * **Curaleaf** – $1.4B | $150–200M | Major cash unlock * **Green Thumb** – $1.1B | $100–150M | Margins 25%+ * **Trulieve** – $1.2B | $120–180M | Huge FCF reversal * **Verano** – $950M | $80–120M | Major EBITDA lift * **Cresco** – $850M | $70–100M | Debt relief + expansion * **Jushi** – \~$260M | $25–35M | Big % improvement * **Cannabist (Columbia Care)** – \~$350M | $35–50M | Margin recovery * **Planet 13** – \~$95M | $9–14M | Small cap, high % benefit * **Marimed** – \~$160M | $15–25M | Thin margins → strongest lift **Why it’s huge:** * Current effective tax rates are **60–70%** for many operators. * Schedule III removes 280E → normal 21–30% corporate tax. * Every MSO becomes more profitable **instantly** once the rule is finalized. **Bottom line:** If this EO drops and DEA confirms Schedule III, this becomes the **biggest single catalyst** the industry has ever had. Massive for MSOs and cash-strapped tier-2 players. 🚀

They have 10B + FCF when you put aside the AI capex But yeah, still not enough

Mentions:#FCF

This market is going nowhere. COST trading at 100x FCF LMAO AVGO trading at 100 PE, chip sales can double but earning can't 5x LMAO LULU losing sales in NA 2% in a quarter, shrinking margins, shrinking EPS LMAO

ORCL’s miss definitely shakes the hype a bit.. negative FCF from AI spending is real money leaving the business. But the market might shrug it off if QE keeps liquidity high and AI excitement stays strong. Could be a short-term pause rather than a full rally killer.

Mentions:#ORCL#FCF

Oracle’s numbers highlight the tension in the AI trade: to stay relevant, everyone has to spend aggressively, but the capex surge temporarily wrecks free cash flow. ORCL missing revenue and posting negative FCF makes the market wonder how many quarters of this the big platforms can absorb before investors start questioning the “AI = infinite margins” narrative. The bigger question is whether this is a company-specific stumble or a preview of what happens when hyperscalers and enterprise players all hit the same capex wall. If multiple AI names start showing the same pattern, that’s when the rally becomes vulnerable. But policy can overshadow fundamentals. If the Fed drifts closer to QE-lite, liquidity alone can keep valuations elevated even while earnings get choppy. That’s why some analysts (think of the style of Ian King Microcap Convergence) focus more on liquidity cycles than quarter-by-quarter results. So in the near term, ORCL might not “break” the AI rally by itself, but it’s the kind of print that becomes important if a few more players confirm the same trend.

Mentions:#ORCL#FCF

The point is you can buy a bond/MM fund with similar yield but there is no real upside potential beyond this yield. If things improve with the company the stock can return capital gains and the company can increase the dividend. If you want higher returns with higher risk - buy tech. If you can't stomach any losses buy risk-free. At this junction, CN has a stable yield at the risk-free rate with a p/e of 15-17, and generating FCF to reinforce the dividend. The current management team took on more debt than ever to buyback stock, and that bet didn't work out. RR typically get better ROIC by expanding rail capacity, not financial engineering. I think they felt pressured to do something because of the CPKC deal and constantly over guiding didn't help. I'm not a huge fan of the current team, but going forward it seems stabilized (grain shipments are at record highs too). Revenue is likely to increase marginally and the cost control measures are in place. Personally, I model this company to return a dividend of 2.5% and capital gain of 3-5% annually over the next few years if the economy grows 1-2%, tariffs remain in effect, and the US dollar does collapse. Weaker USD can lead to lower traffic. The downside is likely limited here, but obviously not guaranteed.

Mentions:#FCF#RR

Don’t point out NVIDIA’s FCF to OP.

Mentions:#FCF

ORCL doing the classic ‘good on paper, ugly under the hood.’ RPO moon numbers look great until you realize FCF is evaporating faster than Larry Ellison’s patience. Feels like one of those quarters where the headlines pump it and the footnotes drag it. Not touching unless it stops pretending the AI boom automatically fixes everything.”

Mentions:#ORCL#FCF

You’re welcome. Still plenty of room to grow. PL has been FCF positive the last three quarters and continues to crush earnings QoQ. Space stocks in general are just beginning to moonshot. ASTS, RKLB, BKSY, etc. are the frontier of a new era. Idc what anyone else says. Look at how bullish the current administration is, including the FCC Chairman who expedited all of ASTS’ approvals. 2026 is going to be a huge year, and yes, I will admit I’m biased AF because I’m balls deep in this area.

AI data centers is a last ditch effort to say this slow dieing company. That FCF 🙈

Mentions:#FCF

RPO is up so adding more worry for investors how ORCL is going to fund the infra capex. Basically, the stock is running on upside down logic. There is not other negative as such, FCF negative due to capex means lot of value investors are out.

Mentions:#ORCL#FCF

11x current FCF, heading to more like 5x FCF by mid 2026

Mentions:#FCF

In past corrections there was almost complete euphoria. People invested and didn't worry. They didn't even look at the market on a daily. There was complete faith that everything would just keep going up! That is not today's market. There is significant pessimism and concern. There are mini pull backs. Industry/sector scrutiny with investors moving between. All this is healthy! Does it mean the market will just go up? No. And everyone understands that. If earnings are strong, companies benefit. If a company has a mis step and can't support the valuation, expect a pullback. Do I expect the market, as a whole in 2026 to deliver the returns we enjoyed in 2025? No! But if I am invested in strong companies, executing well, delivering earnings to support the valuation and strong FCF, then I expect I will do better being invested in the market vs alternatives.

Mentions:#FCF

A mature industry is a natural competitive barrier that prevents new entrants. No one wants to invest the capital required to fight Autozone for a low growth market. FCF is higher, more like $2B. It looks like they’re on a spree of upgrades with how capex has exceeded depreciation in the last few years. Negative book equity isn’t a problem, per se. Frequently, it’s a sign of business strength when you can tap lenders deep below book equity value. E.g., Verisign, Planet Fitness, and Oracle all have (or had) strong free cash flow and high profit margins. This allowed them to borrow with unsecured at reasonable rates below their book equity. It’s only a problem when you also have high cost of debt or financial distress. IMO the stock value still looks a little rich. They had one of the best stock returns of the last 25 years — over 100x. Even though their profit growth was average, they perpetually traded at a low multiple and juiced returns through stock buybacks. I guess this new high multiple is the market correcting itself.

Mentions:#FCF

In this bubble of ai/software they were actually a pretty good value play, trading at 6xs sales so thats a good pickup for something growing with good FCF. Theres more smaller software out there like that.

Mentions:#FCF

If he was able to see the future dont you think he would have kept it? He sold a lot of it to buy worse companies. I know why he sold it, but it still reflected his lack of foresight or confidence. Each company must be evaluated independently and fairly. Its harder to cheat FCF and its there, there is no ai bubble. 

Mentions:#FCF

These tech companies. Going from low capital, higher than fuck margins and historic FCF. To vertically integrated, high capital, cash sucking data center companies. Brilliant

Mentions:#FCF

Meaning they have $19B cash and $25b debt. They generated $5.85B FCF last quarter while paying dividends and buying back shares. Market cap is $642B. They can pay all their debt next quarter if they want to.

Mentions:#FCF
r/stocksSee Comment

Metaverse is a shit show, yes it will be a sunk cost. they burnt like 17B on the metaverse last year. The market didn't like that FCF being down q3 2025 on q3 2024. This wil change with money big chunk of money from the metaverse moving to Ai spend or to buybacks.

Mentions:#FCF

There are many stock analysis sites that provide insider trading with names of insiders. He has been selling like this for the whole year. It's hard to invest when executives have so many shares and stock based comp. This company takes all of its 3% FCF and gives it to employees. Thats what makes it risky so buyer beware. [Heres the last ten insider trades. ](https://imgur.com/a/c4qV75f)

Mentions:#FCF

I loaded the boat on META AMZN TSLA during the panic the past couple of weeks. Those were my focus stocks for 2026 (alongside GOOGL and UNH which I already own). I entered into starter positions in RBRK and PATH (very small position honestly, they need to show growth accelerating and and DBNR over 120% for me to be real bullish, but just gamble sized) today which I think could end up being good winners next year (both should get bought out).  I’m also eying BA as a value play now that they’re flipping FCF positive. And would buy RL for some non tech exposure if it consolidated or corrects a little. 

Gotta keep the debt pile growing to keep that FCF for share buybacks to keep exec compensation as high as possible.

Mentions:#FCF

Focus your prompts on structure, sources, and falsifiability rather than “give me picks”: e.g., “You are a buy‑side analyst, break down {SECTOR} in plain English: 3 secular growth drivers vs 3 cyclical headwinds; 5 KPIs experts track (define each); key regulatory/supply‑chain risks; and a table of the top 10 holdings of {SECTOR ETF} with 3‑yr revenue CAGR, FCF margin, net debt/EBITDA, ROIC.” Then: “Using {SECTOR ETF} constituents, rank a top‑5 by a transparent composite, growth 40%, profitability 30%, balance sheet 20%, valuation 10%, show your math and uncertainty.” For single names: “Explain {TICKER}, give 5 bull/5 bear points, 3 catalysts with ‘what would falsify this?’ indicators, and red‑team the thesis.” I sanity‑check LLM output with a simple signal dashboard like **Prospero.ai’s** 10 signals (0–100) to avoid pretty‑sounding narratives; you still make the call (NFA).

Mentions:#FCF

This is a volatile stock sure but it’s been falling since September. If you are buying it 2 weeks in after the big dip, you need to wait a lot more for this pay off. Especially since your breakeven price is +30% off. Price that far off is unreachable unless there is a major catalyst and you have not put that in the reasoning other than FCF. Not for me I guess.

Mentions:#FCF

FCF is what counts

Mentions:#FCF

Operating income was down 40% YoY in 2022. It was lower than FY 2020, too. Reality Labs’ loss had increased from $6.6B in 2020 to $13.7B in 2022. Free cash flow halved year over year, primarily because capex jumped 66% in 2022. Most of that money was investment for Reality labs. FCF was the lowest it had been since 2018. Family of apps was still highly profitable, but reality labs was weighing heavily on their consolidated financial picture. It rebounded because Zuckerberg cut RL’s spending.

Mentions:#FCF#RL

Revenue of $20B, $14.4B debt, FCF $2.2B Buy it

Mentions:#FCF

Data center problems with power are just now starting to bite. Why do you think they all just raised capital? They are getting to close to being FCF negative

Mentions:#FCF

My math doesn’t make sense? Why? Because it doesn’t fit your narrative? 2020 12.87 billion (15.2%) 2021 15.8 billion (22.67%) 2022 17.61 billion (11.54%) 2023 19.41 billion (10.24%) 2024 21.51 billion (10.8%) 2026 projected 25.87 billion (9.21%). Your math skills are severely lacking or you’re saying bullshit because of your bias. That’s deceleration of 30-50% with revenue over the last five years. In regard to free cash flow—did you even check the financial statement? You can clearly see net income jumped from unusual items. It’s a crazy outlier from the previous years which explains the “FCF growth” if you normalize it like any sane investor would. Then no-they did not grow FCF at 47% Lastly, spending all their FCF on buybacks with deceleration is ADBEs management waving the white flag. They spent 12 billion on stock buybacks with 5 billion SBC adjusted free cash flow. What the actual F? That’s more than double what they make. That won’t continue. Plus, buying back 20% of stock over the next 2 years is 10% returns a year. Which brings me back to the point. Buy the SP500 for the same or better returns with much much less risk.

Mentions:#FCF#SBC

That recovery is dependent on Zuck not blowing through all their FCF on projects that aren't proven returns on investment.

Mentions:#FCF

-45% YoY quarterly revenue growth -139.61% Profit Margin -25.59% operating margin (ttm) -1.98B operating FCF these are just some things I noticed at a quick glance. it looks like they need a hail mary miracle at this point.

Mentions:#FCF

Looks more like a repricing of leverage and rate risk as Oracle front loads AI capex with thinner near term FCF and Cerner drag, so watch FCF-to-interest, net leverage, the maturity ladder, and CDS vs peers to judge crack vs cycle noise; you can find more at mr-profit com.

Mentions:#FCF

Nvidia have a good estimated EPS growth for next year but that will decline fast in the coming years. AMD is projected to accelerate their growth and surpass nvidia in growth from mid-2026. AMD is cheaper in forward PE and PEG for earnings from 2027 and onwards. TSM is traded higher in terms of PEG because they have a lower current valuation (higher OCF and FCF yield) and also deliver to broadcom and google, which makes it a less volatile investment. If broadcom or google takes market share from nvidia and AMD then TSM still wins.

# Financial Health & Ratios Based on the most recent financial data available (as of **November 14, 2024**, Yahoo Finance and Simply Wall St): || || |Metric|Value (as of Nov 2024)| |**Market Cap**|\~$9.11M (intraday)| |**Enterprise Value (EV)**|$6.48M| |**Cash on Hand (mrq)**|$3.43M| |**Current Assets vs. Liabilities**|Not fully disclosed, but short-term assets exceed liabilities per WallStreetZen \[July 24, 2025\]| |**Long-term Debt**|Not disclosed; Debt/Equity ratio not available| |**Debt-to-Equity Ratio**|Not available (marked as "--")| |**Interest Expense**|Not disclosed| |**EPS (TTM)**|**-$1.82**| |**Return on Equity (ROE)**|**-1,191.73%**| |**Net Margin**|**-47.28%**| |**Book Value**|Not available| |**Market-cap-to-cash ratio**|\~2.66x ($9.11M / $3.43M)| |**Annual Cash Burn**|\~$4.51M (Levered FCF TTM)| |**Estimated Cash Runway**|\~9–10 months (based on $3.43M cash and \~$4.51M annual burn)| The company is **not profitable**, with negative EPS and ROE, and has **missed earnings expectations** in multiple recent quarters (Q1, Q3 2025). The **forecast breakeven date has been pushed back to 2027** \[Simply Wall St, Oct 5, 2024\], and there are **going-concern warnings** implied by negative equity and cash burn.

Mentions:#EV#ROE#FCF

# Financial Health & Ratios Based on the most recent financial data available (as of **November 14, 2024**, Yahoo Finance and Simply Wall St): || || |Metric|Value (as of Nov 2024)| |**Market Cap**|\~$9.11M (intraday)| |**Enterprise Value (EV)**|$6.48M| |**Cash on Hand (mrq)**|$3.43M| |**Current Assets vs. Liabilities**|Not fully disclosed, but short-term assets exceed liabilities per WallStreetZen \[July 24, 2025\]| |**Long-term Debt**|Not disclosed; Debt/Equity ratio not available| |**Debt-to-Equity Ratio**|Not available (marked as "--")| |**Interest Expense**|Not disclosed| |**EPS (TTM)**|**-$1.82**| |**Return on Equity (ROE)**|**-1,191.73%**| |**Net Margin**|**-47.28%**| |**Book Value**|Not available| |**Market-cap-to-cash ratio**|\~2.66x ($9.11M / $3.43M)| |**Annual Cash Burn**|\~$4.51M (Levered FCF TTM)| |**Estimated Cash Runway**|\~9–10 months (based on $3.43M cash and \~$4.51M annual burn)| The company is **not profitable**, with negative EPS and ROE, and has **missed earnings expectations** in multiple recent quarters (Q1, Q3 2025). The **forecast breakeven date has been pushed back to 2027** \[Simply Wall St, Oct 5, 2024\], and there are **going-concern warnings** implied by negative equity and cash burn.

Mentions:#EV#ROE#FCF

its not contracting revenue they are growing while trashing the donuts in grocery store regardation … they are growing. FCF positive and can manage their debt. They arent absolutely crushing it - but they shouldnt be sub 7x ‘26 FCF. There ya go^

Mentions:#FCF

Well, I don't know how long they can sustain it, but they're going to have a MONSTER year next year. They'll have 250B+ in FCF in F'27. At THAT point, there has to be more of a return on investment or at least we have to be moving closer to one outside of just AMZN, MSFT, and GOOGL. I'd say the next decade of AAPL is safer. The next Decade of NVDA has more upside and more downside(much more of both). But the next \~18 months... that should easily be NVDA.

Boeing sees FCF 'closer to' 2B Boeing CFO says $10B long-term cash goal attainable Boeing CFO sess recovery 'in full force' BA +3.25% in the last 2 minutes lol

Mentions:#FCF#BA

Because they are going to implement Gemini and they didn’t have to blow through years of FCF to do it.

Mentions:#FCF

AAPL’s FCF has been stagnating for like 16 quarters yet still hitting ATH’s

Mentions:#AAPL#FCF

More like Apple doesn’t want to blow through years of FCF to do what its business partner, GOOG, is already doing. I love how it’s bearish sentiment for a company to not spend $100$+ building out infrastructure with no obvious ROI.

Mentions:#FCF#GOOG

I was about to say, cormedix is criminally undervalued with a EV/FCF of like 3-4 and a rapidly growing business. One of my biggest holdings

Mentions:#EV#FCF

I get the concern, but I think the competitive picture is more nuanced. Lilly’s drugs may show stronger efficacy on some metrics, but the GLP-1 market isn’t winner-take-all — it’s supply-constrained, demand is global, and switching costs for patients are extremely sticky. Novo doesn’t need to be the best drug to compound; it just needs to continue being one of the two dominant suppliers in a market where demand massively exceeds capacity. As for pricing power and margins, those are determined by payers and regulators, not consumer choice, and both companies are still negotiating from a position of strength. Growth is slowing from extraordinary to normal, but FCF, margins, and global penetration still support long-term compounding. Being first to scale — not just first to market — is a moat that doesn’t decay nearly as fast as people assume. Either way you don’t “print cash” on stock price — stock is associated with sentiment and hype. The core finances prove that novo is a financial stalwart even if you personally like their competition better.

Mentions:#GLP#FCF